According to US researchers, healthy boys are more likely to be taken to the hospital as a result of a rare side effect of the Pfizer/BioNTech Covid vaccination, which causes cardiac inflammation, than as a result of Covid itself. According to their review of medical data, boys aged 12 to 15 who have no underlying medical issues are four to six times more likely to be diagnosed with vaccine-related myocarditis than boys aged 12 to 15 who are admitted to the hospital with Covid over a four-month period.
South Africa is currently in Lockdown Level 4 as a result of the high rates of Corona Virus cases, President Cyril Ramaphosa has also implemented some strict restrictions in the country, including restricting most social gathering and also restricting all alcohol sales in the country, amongst other restrictions.
https://www.businesslive.co.za/bd/world/2021-07-23-pfizer-vaccine-very-effective-at-stopping-hospitalisation-but-less-so-at-infection/ Pfizer's Covid-19 antibody gave a solid safeguard against hospitalization and more extreme illness in cases brought about by the infectious Delta variation in Israel lately, despite the fact that it was simply 39% compelling in forestalling diseases, as per the country's wellbeing service.
If you receive a COVID-19 vaccine and think you have a severe allergic reaction, leave the vaccination site immediately, seek immediate medical attention or call 911. The most common side effects are symptoms similar to those of Covid-19, and the following symptoms indicate that Covid-19-infection may not be caused by the vaccine.
Source World Health Organization & forbes.com In this age of covid 19 vaccines, one wonders how much the manufacturers of these vaccines have made up to this point. Every pharmaceutical product is expected to take millions once it reaches shelves and establish itself. With the three covid vaccines currently available, namely BioNTech, Moderna and Pfizer, profits have been unimaginable.
Moderna said on Thursday its Covid-19 shot was about 93% powerful through a half year after the subsequent portion, showing barely any change from the 94% adequacy announced in its unique clinical preliminary. That analyzes well to information from Pfizer and BioNTech last week in which they said their immunization's viability disappeared around 6% each two months,declining to around 84% a half year after the subsequent shot.
Pfizer and BioNTech on Monday submitted fundamental clinical information to US wellbeing specialists, as a feature of their work to look for approval for a third portion of their Covid-19 immunization for all Americans. Last week, the US supported the promoter shot of Pfizer-BioNTech and Moderna immunizations, for individuals with debilitated safe frameworks.
HONG KONG - People who accepted BioNTech's Covid immunization had multiple times the measure of antibodies than those given China's Sinovac, a Hong Kong study has shown, adding to developing information on various punches' adequacy. The University of Hong Kong (HKU) research, in view of an investigation of 1,442 medical care laborers, was distributed in Lancet Microbe on Thursday.
The Covid pandemic has made antibodies from Pfizer/BioNTech and Moderna and the mRNA innovation, that they use into easily recognized names. These sorts of punches are new however specialists have been working for quite a long time to attempt to sort out some way to utilize courier RNA, for different inoculations and to get ailments from AIDS malignant growth.
http://ewn.co.za/lna9p CAPE TOWN - Biovac said the organization with Pfizer/BioNTech was a critical advance towards the landmass turning out to be increasingly more independent. The biopharmaceutical organization has secured an arrangement with Pfizer to finish the creation of its immunization at its Cape Town plant. It's likewise set to supply dosages to nations in the African Union.
People are surprised after hearing that the head of BioNTech, the German company that developed the first Covid-19 vaccine, said a new formula is likely to be needed by mid-2022 to protect against future mutations of the virus. This is a sign that they could be more variants which will be coming and some people think that this will only affect the unvaccinated.
http://ewn.co.za/xxaua PARIS - As the Delta variation spreads quickly all through the world, the possibility of a third "sponsor" shot is acquiring interest even in countries where a huge extent of individuals are inoculated. Specialists say it is too early to know without a doubt if nations should sort out a third antibody round later in the year.
Pfizer producers are smiling all their way to the bank as the vaccine climbed about 9% in the four trading days through Tuesday with trades totaling up to $63million of the shares. Since then it has shown to be the favored COVID-19 vaccine stock. The day trading crowd sold off more positions than they bought in Moderna and BioNTech and it makes sharp changes in fortunes.
Pfizer and BioNTech have submitted data to the US Food and Drug Administration (FDA) in support of a third dosage of the Covid-19 vaccine being evaluated. People who received a third dose of the mRNA vaccine had a “favorable safety profile and substantial immunological responses,” according to the firms.
Pfizer says inoculation got, sensible for youngsters ages 5 to 11. Pfizer says Covid inoculation is reasonable for youngsters ages 5 through 11. Data shows the Pfizer and BioNTech Covid inoculation is gotten and sensible for teenagers ages 5 to 11, the affiliations proclaimed Monday morning.
Pfizer and BioNTech say kids in preliminaries responded well to the antibody and that their resistant reaction was "vigorous", and "equivalent" to that saw in more seasoned teenagers and youthful grown-ups matured 16 to 25. In the event that the FDA awards authorisation when it meets on October 26, kids in that age range – - of whom there are exactly 28 million in the US — could begin getting immunized before the month's over.
Drug organizations Pfizer and BioNTech have submitted information to the US Food and Drug Administration (FDA), to help the assessment for a third portion of the Covid-19 antibody. The organizations said in a proclamation that individuals who got a third punch of the mRNA immunization, showed "a great wellbeing profile and vigorous insusceptible reactions."
Pfizer and BioNTech said they are fostering a Covid-19 supporter shot planned to focus on the exceptionally contagious Delta variation, as per US media writes about Thursday. Concerns keep on ascending as the Delta strain has effectively gotten the prevailing variation in many pieces of the world, causing expanding diseases.
Pfizer and BioNTech have marked a letter of goal with Biovac, a Cape Town-based biopharmaceutical organization, to fabricate the Pfizer-BioNTech Covid-19 antibody for appropriation inside the African Union. To work with Biovac's association all the while, specialized exchange, nearby turn of events and hardware establishment exercises will start quickly, Pfizer said in a press proclamation on Wednesday (21 July).
SA to start making Pfizer vaccine – Pharmaceutical companies BioNTech and Pfizer yesterday said they had found a South African partner to produce their Covid vaccine locally, the first such deal in Africa. The move comes amid growing criticism of vaccine inequality that has seen poor countries fall behind richer ones in the race to protect people from the coronavirus.